CONNECT WITH US
HealthTech

HealthTech

Elevance sees Medicaid momentum in Q3

Healthcare Dive logo

Published on

Add as a preferred source on Google
Elevance sees Medicaid momentum in Q3

States jacked up their Medicaid rates in July, a positive development for the insurer. Elevance now thinks its Medicaid margin will be slightly better than -1.75% this year.

Elevance posted net income of $1.4 billion in the third quarter, up almost 15% year over year, despite revenue of $51.4 billion remaining essentially flat.

The positive results were expected after upbeat commentary from executives during the Indianapolis-based insurer’s investor day last month. It was a “solid” quarter, TD Cowen analyst Ryan Langston commented in a Wednesday note.

Elevance is mostly known for its Blues-licensed plans but also operates in a variety of government programs, including Medicaid. The insurer covers 8.2 million beneficiaries of the safety-net insurance program in more than a dozen states.

But Medicaid has posed a challenge since 2024, as its population became sicker and necessitated higher spending on their care. State rate updates have trailed rising acuity, tamping down on profits for managed care organizations.

The mismatch spurred Elevance to exit Washington, D.C.’s Medicaid market this summer, and share plans to leave additional Medicaid markets through the end of 2027.

But stronger-than-expected July 1 rate updates from some states are boosting Elevance’s Medicaid performance, executives said on the earnings call.

Elevance still continues to expect 2026 to be a trough year for Medicaid margins, before they bounce back in 2027. The insurer is still focused on curtailing costs, including by restricting behavioral healthcare like applied behavioral analysis therapy for individuals with autism, which has been a major driver of spending.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.